Hikma Pharmaceuticals

As we wrap up the final day at CPHI Milan 2026, our team has valued the opportunity to connect with partners, customers, and industry peers from across the sector who share our vision of developing and manufacturing high-quality generic and specialty medicines and making them accessible to those who need them. If you missed us at our booth, we’d still love to hear from you! Reach out to our team to discuss: Injectables & 505B2 Branded Hospital Portfolio For North America: Natrajan Kumaraperumal | Marine Lazouret For Canada: Mike Armstrong For Europe: Ana Santos Perez | Carolina Myers Luzia Generic nasal and oral solid and liquid doses For North America: Brett Bukvic | Jaweed Zabian | Michael Balog | Chris Edlin Generic / Branded portfolio for MENA: Kareem Darwazah | Lama Shatara | Sanaa Sunaa | Ahmad Rimawi | Sevaneh Dabbour Group-level partnerships, M&A, and strategic initiatives: Faisal Darwazeh | Hani Al-Saheb | Isabel Fernandez Acin Animal health: Jaweed Zabian Procurement: Haya Mughrabi | Rui Custódio | Zeina Mustafa | Hadeel Tallawi | Maria Sofia Lopes CMO: Doug Peterson | Bárbara Pereira Thank you to everyone who connected with us during CPHI Milan 2026. We look forward to continuing our discussions and exploring new opportunities together! https://www.hikma.com/

For more than three years, we've worked alongside Health Partners International Canada (HPIC) to help increase access to medicines for people who need them most. Since 2022, our partnership has enabled the donation of more than $2 million worth of essential medicines, helping support communities facing barriers to healthcare. This is what putting our purpose into action looks like. Read more about how we make an impact: https://lnkd.in/ebAhp_nP

Day 2 at CPHI Milan is underway! We've been enjoying the many great conversations and connections we've made so far and are looking forward to meeting even more partners today. Visit the Hikma stand 16H6 and meet our Business Development team to explore opportunities across the pharma industry. Injectables & 505B2 Branded Hospital Portfolio For North America: Natrajan Kumaraperumal | Marine Lazouret For Europe: Ana Santos Perez | Carolina Myers Luzia   Generic nasal and oral solid and liquid doses For North America: Brett Bukvic | Jaweed Zabian Generic / Branded portfolio for MENA: Lama Shatara | Sanaa Sunaa | Ahmad Rimawi Group-level partnerships, M&A, and strategic initiatives: Faisal Darwazeh, Hani Al-Saheb Animal health Jaweed Zabian

Congratulations to Matt Pierce, Director of Operations at our Injectables manufacturing site in Cherry Hill, New Jersey, for being named to the inaugural 40 Under 40 list by BioSpace. As a news hub for the life sciences industry, BioSpace is highlighting innovation, business impact, and commitment to improving patient outcomes. This outstanding achievement is a powerful testament to Matt’s exceptional leadership, relentless dedication, and his passion for Hikma’s mission of helping patients and health care providers with a reliable supply of high-quality medicines. In his 8 years with Hikma, Matt has worked in manufacturing, supply chain, and compounding operations, delivering value in every role. Being selected by an independent and respected organization such as BioSpace makes this recognition especially meaningful. It highlights not only Matt’s significant accomplishments to date, but also the impact, innovation, and excellence that continue to distinguish his contributions. We’re delighted you are on our team, Matt! Enjoy this well-earned recognition.

Hikma Pharmaceuticals is excited to attend Premier Breakthroughs 26 at the Gaylord National Resort & Convention Center in National Harbor, MD, October 6-8, 2026. We look forward to connecting with healthcare leaders, customers, and industry partners, sharing insights, and exploring innovative solutions that help improve patient outcomes and advance healthcare delivery. Be sure to stop by Booth No. 808 to meet the Hikma team and learn more about our commitment to helping patients access high-quality medicines. We look forward to seeing you there! Kali Long Joe Schrick Tyson Osborn

With five injectables manufacturing plants, seven commercial offices and one R&D hub, our 1,400 colleagues support Hikma's European business. This network sits at the heart of our global Injectables business and has made us the fourth-largest supplier of generic injectable medicines in Europe [1]. Our manufacturing network provides expertise across a broad range of injectable technologies, including liquid and lyophilised formulations, helping us meet the needs of patients and healthcare providers across Europe and beyond. As we continue to invest in and expand our capabilities, we are strengthening our ability to serve customers, partners and healthcare systems. We also put this expertise to work for others through our contract manufacturing (CMO) services, helping partners bring their injectable medicines to market. Learn more about our European operations, in our factsheet: https://lnkd.in/e4tF9Whh [1] IQVIA Midas Disease Quarterly Sales data for Hospital generic injectables + Retail generic injectables Germany. MAT Dec2025- USD sales (excluding all biosimilars) Countries in scope: Austria, Belgium, Finland, France, Germany, Italy, Norway, Poland, Portugal, Spain, Sweden, UK

In the latest edition of our Inspired at Hikma series, meet Lama Shatara, Senior Director, Business Development & Alliance Management - MENA. Lama shares how building strong partnerships, fostering collaboration and understanding local healthcare needs help bring more medicines and healthcare solutions to patients across the region. Read more here: https://lnkd.in/eZ7e_p2R

We were proud to host the second Full Line Wellness (FLOW 2) meeting in Alexandria, bringing together more than 100 physicians specialising in paediatrics and pulmonology to continue important scientific discussions around infection prevention and management. The meeting provided a platform for knowledge sharing and scientific exchange, with discussions focused on respiratory infections across different age groups and evidence-based approaches that support better health outcomes across Egypt. تشرفنا باستضافة فعاليات FLOW 2 (Full Line of Wellness) في الإسكندرية، بمشاركة 100 طبيب متخصص في طب الأطفال والأمراض الصدرية، لمواصلة النقاشات العلمية حول الوقاية من العدوى وإدارتها. وشكّل اللقاء منصة لتبادل المعرفة والخبرات العلمية، حيث ركزت المناقشات على التهابات الجهاز التنفسي لدى مختلف الفئات العمرية، وأهمية تبني الممارسات المبنية على الأدلة العلمية لدعم تحسين النتائج الصحية للمرضى وتطور الرعاية الصحية في مصر.

Today is Manufacturing Day (MFG Day) in the United States! We are proud to host students at our Columbus site to provide them with a closeup look at how we make essential medicines for the millions of American patients who need them. Through a tour of our facility and conversations with our experienced professionals, these high school and technical school students are seeing the skills and technologies we use in our best-in-class pharmaceutical manufacturing operations. The future of American manufacturing and good jobs depends on experiences like these. Hikma is currently hiring for pharmaceutical manufacturing jobs in Columbus, Ohio, Bedford Ohio and Cherry Hill, New Jersey. https://brnw.ch/21x67U2 #MFGDay26 @MFGDay

Last week, we concluded the 8th Annual MENA Cancer Forum, Hikma Cancer Network 2026, bringing together more than 200 oncology professionals and over 20 international experts from across the region and beyond. As oncology continues to evolve, scientific exchange and collaboration play an important role in advancing cancer care. The forum welcomed experts from leading institutions, including the MD Anderson Cancer Center, to share knowledge, exchange perspectives and discuss the latest developments in oncology. By bringing healthcare professionals together to learn from one another and share expertise, we are helping advance oncology knowledge and support better outcomes for people living with cancer across the region. Know more about our business in MENA: https://lnkd.in/euVt3Zbx